BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model
Nonalcoholic fatty liver disease (NAFLD) is a prevalent hepatic disease in the world. Disorders of branched chain amino acid (BCAA) metabolism is involved in various diseases. In this study, we aim to explore the role of BCAA metabolism in the development of NAFLD and the protective effect of BCATc...
Main Authors: | Zhuo Lu, Gui-Feng Sun, Xiao-An Pan, Xin-Hui Qu, Ping Yang, Zhi-Ping Chen, Xiao-Jian Han, Tao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1025551/full |
Similar Items
-
Retracted: Wogonoside promotes apoptosis in gastric cancer AGS and SGC‐7901 cells through induction of mitochondrial dysfunction and endoplasmic reticulum stress
by: Xiao‐Miao Hu, et al.
Published: (2019-08-01) -
Chrysophanol-8-O-glucoside protects mice against acute liver injury by inhibiting autophagy in hepatic stellate cells and inflammatory response in liver-resident macrophages
by: Tao Wang, et al.
Published: (2022-09-01) -
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function
by: Maria J. Gonzalez-Rellan, et al.
Published: (2023-09-01) -
Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
by: Youwei Zheng, et al.
Published: (2023-07-01) -
The role of intestinal disbiosis in the development of mitochondrial dysfunction and nonalcoholic fatty liver disease
by: P. V. Seliverstov, et al.
Published: (2018-04-01)